Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Dermatologic 1

Conditions

Melanoma 1 Hepatitis 1 Colitis 1

Interventions

pembrolizumab 77 Nivolumab 64 Ipilimumab 40 Specimen Handling 33 Magnetic Resonance Spectroscopy 27 Cyclophosphamide 26 Biopsy 20 cemiplimab 16 fludarabine 14 Radiosurgery 14 relatlimab 13 CTLA-4 Antigen 13 binimetinib 12 Opdualag 12 trametinib 11 fludarabine phosphate 11 avelumab 9 Immunoglobulin G 9 Blood Specimen Collection 9 lifileucel 8 dabrafenib 8 atezolizumab 8 Radiotherapy 8 Disulfides 8 encorafenib 7 aldesleukin 7 X-Rays 7 Paclitaxel 7 Standard of Care 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

vedolizumab × Dermatologic × 90 days × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡